Ex-AstraZeneca Exec Hoefer Joins Arcus as Chief Commercial Officer

Xconomy San Francisco — 

Arcus Biosciences (NYSE: RCUS) has appointed Eric Hoefer to serve as chief commercial officer. Hoefer most recently worked at AstraZeneca (NYSE: AZN), where he led immune-oncology global marketing. His experience also includes posts at Roche and Genentech. Hayward, CA-based Arcus raised $120 million in an IPO last year to fund clinical development of its experimental cancer immunotherapies.